EXNA Drug Patent Profile
✉ Email this page to a colleague
When do Exna patents expire, and what generic alternatives are available?
Exna is a drug marketed by Ah Robins Inc and is included in one NDA.
The generic ingredient in EXNA is benzthiazide. There is one drug master file entry for this compound. Additional details are available on the benzthiazide profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for EXNA?
- What are the global sales for EXNA?
- What is Average Wholesale Price for EXNA?
Summary for EXNA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 64 |
| Patent Applications: | 3,662 |
| DailyMed Link: | EXNA at DailyMed |
US Patents and Regulatory Information for EXNA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ah Robins Inc | EXNA | benzthiazide | TABLET;ORAL | 012489-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
